John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Should You Buy Kroger Co? 2 Pros, 2 Cons

By John Kilhefner, Senior Managing Editor, Lango Franchise

Kroger stock has been nearly halved from its all-time high and encroaching competitors the likes of which grocers have never seen are hurting margins at KR. Does Kroger Co. have a strong enough bull case to warrant buying here, or are the bears in control?

4 High-Yield, High-Risk Dividend Stocks That Aren’t Worth It

By John Kilhefner, Senior Managing Editor, Lango Franchise

A high-yield dividend can be an attractive aspect to a stock, but that number alone doesn't make a stock worth buying.

5 Giant-Slaying Small-Cap Stocks to Buy

By John Kilhefner, Senior Managing Editor, Lango Franchise

Small-cap stocks with strong earnings growth and down-to-earth valuations are performing better than even the largest of blue chips.

Top 10 Best Stocks to Buy in the S&P 500 Through Q3

By John Kilhefner, Senior Managing Editor, Lango Franchise

The best stocks to buy right now in the S&P 500 through the third quarter thrive on the 'Trump trade' and strong fundamentals.

Amazon.com, Inc. (AMZN) Stock Tops $1,000 Thanks to Record Prime Day

By John Kilhefner, Senior Managing Editor, Lango Franchise

Amazon's Prime Day was a record-setting success that included a huge influx of fresh Prime customers. That sent AMZN stock back above $1,000 for the first time since June.

Dynavax Technologies Corporation (DVAX) Stock Earns a Double-Digit Lift

By John Kilhefner, Senior Managing Editor, Lango Franchise

Dynavax's SD-101 just got through a Phase 1b/2 clinical trial with a trio of positive points, sending DVAX stock up by double digits Monday.

Herbalife Ltd. (HLF) Stock Wilts After China Head Departure

By John Kilhefner, Senior Managing Editor, Lango Franchise

Herbalife (HLF) is drowning as reports suggest the head of China operations has been removed. HLF stock is now down nearly 6%.

Sorl Auto Parts, Inc. (SORL) Stock Pops 22% as Buzz Grows

By John Kilhefner, Senior Managing Editor, Lango Franchise

Sorl Auto Parts is flying high after Zacks gave it bullish attention, which comes on the heels of a big post-earnings bump in SORL stock.

GlycoMimetics Inc (GLYC) Stock May Find Its Way to Profitability

By John Kilhefner, Senior Managing Editor, Lango Franchise

It's not a household name, but GlycoMimetics is now on the fast track to profits, giving GLYC stock a much-needed boost.

Etsy Inc (ETSY) Stock Pops 24% on a Big Activist Stakes

By John Kilhefner, Senior Managing Editor, Lango Franchise

Etsy hasn't felt so hot lately, but the potential of a sale and the urging of an activist fund could spell change for ETSY stock.

Load More